5D·

👺

First small dip, with the hope that it will fall further ✨

14.07
Novo Nordisk logo
Bought x10 at DKK 438.00
DKK 4,380.00
13
24 Comments

profile image
You buy shares that have fallen 50% in the hope that they will continue to fall. This is called negative investing.
29
profile image
@Smudeo The aim is to make even more purchases more cheaply than now.
profile image
@SmudeoKeyword : falling knife😎
@Smudeo Noco is a fashionable share. Everyone is buying because it has fallen so sharply, in the hope that it will go up again at some point. You can do that, but you don't have to. I don't see any sense in it at the moment.
2
profile image
@Transporter If you take Novo for what it was before the hype: a dividend stock, I can understand purchases.
Only as you have already correctly written: Hope for old prices.
1
@Dividenden_Monteur What stands in the way of old courses?
profile image
@PIXELINVESTOR In the short term, as some people here think, quite a bit.
In the long term, not much.

It's just that some people here don't think long-term
3
profile image
It was a fashion stock when it rose to 1000 DKK, I think small entries are realistic for a long time. I find it funny how people get upset here but encourage other people to buy Bitcoin at the ATH. While I was writing this text, a seagull pooped on my arm.
9
profile image
@Shikamarru See it positively a seagull shit should bring luck and as @Dividenden_Monteur writes not suitable for a short-term trade, long-term b&h yes, but I also have to say it wasn't a dip today and be glad that Seeebi is no longer with us 😂
3
profile image
I don't know him, but I think we would be friends!
profile image
@Smudeo I've been here on the platform since 2022 and every year more idiots come in here who make pointless posts and obviously have no idea what they're actually doing with their money. My favorite was the guy who bought a stock because of the cool name :D
1
View all 2 further answers
I never buy... Trend share
2
@Roots Nope. The share price has been rising steadily for 40 years, from bottom left to top right.
Not a trend share. Most people here don't understand that. GLP1 receptor agonists are only a small part of what this company does every year in the field of diabetes therapy worldwide.
4
@Roots Production of insulin and weight loss products in a fat modern world is a forever trend. Not comparable with short-term hypes such as ESG (Environmental / Social / Governance such as hydrogen, wind, biogas, ...)
@user28461 apart from the fact that novo nordisk has tradition... ok...
everyone is currently jumping on this investment bandwagon...
This is a trend for me...and makes rock solid investments difficult...

When people talk about a free trend...
I work in the care sector...
novo shares this forever trend with many forever trend providers...

As far as insulin and slimming injections are concerned, it's an old shoe, so to speak...
Some shops can do that.

What else novo does - 👍
But please note: the current buying frenzy is mainly based on a world populated by fat people who all need insulin, only use novo products and have no other way out of obesity
Rather buy $LLY, have developed a weight loss product that is 47% more effective than that of $NOVO B:
https://www.drugdiscoverytrends.com/tirzepatide-shows-47-greater-weight-loss-than-semaglutide-in-72-week-phase-3b-study/
2
profile image
Thank you for the recommendation. I did some research before buying. It is also an interesting share for me. However, Novo has more professional experience in this sector and is more broadly based. I've had my eye on it for a while because of its growth.
profile image
Where is there a dip?
profile image
@Dividenden-Sammler It will continue to fall, so congratulations, it's going exactly how you want it.......😂😂
2
profile image
I'm invested and believe in a recovery, but there was no reason today to enter, seriously
2
profile image
@Dividenden-Sammler I would say the dip will be around 400 DKK.
Join the conversation